Files
republic-os/legislation/us/states/tn/114/hb-1239.md
T
2026-07-06 17:28:36 -04:00

4.6 KiB

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63. Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63. us/states/tn Tennessee General Assembly 114 HB 1239 Tennessee HB 1239 (114)
bill
Opioids
enacted
Helton-Haynes
3 27 0 2025-02-06 2025-04-28 openstates ocd-bill/7b282135-c886-44b0-bad3-76758bbbc006 https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1239&ga=114 0265be448a415688bf6207011a56286d7a093402ed1028a9d9307dcf4005a3d6 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-tn

Tennessee HB 1239 (114) — Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Amendment HA0252 (committee substitute) — source
  2. Amendment SA0095 (committee substitute) — source
  3. Current Version (committee substitute) — source

Sponsors

  • Helton-Haynes — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2025-02-06 Filed for introduction filing
  • 2025-02-10 Intro., P1C. introduction
  • 2025-02-12 Assigned to s/c Health Subcommittee referral-committee
  • 2025-02-12 P2C, ref. to Health Committee referral-committee
  • 2025-03-12 Placed on s/c cal Health Subcommittee for 3/19/2025
  • 2025-03-19 Placed on cal. Health Committee for 3/25/2025
  • 2025-03-19 Rec for pass if am by s/c ref. to Health Committee referral-committee
  • 2025-03-25 Action def. in Health Committee to 4/1/2025
  • 2025-03-26 Placed on cal. Health Committee for 4/1/2025
  • 2025-04-01 Rec. for pass. if am., ref. to Calendar & Rules Committee committee-passage-favorable
  • 2025-04-02 Placed on cal. Calendar & Rules Committee for 4/3/2025
  • 2025-04-03 H. Placed on Regular Calendar for 4/7/2025
  • 2025-04-07 Passed Senate, Ayes 27, Nays 4 passage
  • 2025-04-07 Amendment withdrawn. (Amendment 1 - SA0095)
  • 2025-04-07 Senate substituted House Bill for companion Senate Bill. substitution
  • 2025-04-07 Received from House, Passed on First Consideration introduction
  • 2025-04-07 Engrossed; ready for transmission to Sen. receipt
  • 2025-04-07 Passed H., as am., Ayes 92, Nays 1, PNV 0 passage
  • 2025-04-07 Sponsor(s) Added. sponsorship
  • 2025-04-07 H. adopted am. (Amendment 1 - HA0252) amendment-passage
  • 2025-04-08 Enrolled; ready for sig. of H. Speaker. enrolled
  • 2025-04-10 Signed by H. Speaker passage
  • 2025-04-14 Signed by Senate Speaker passage
  • 2025-04-16 Transmitted to Governor for his action. executive-receipt
  • 2025-04-24 Signed by Governor. executive-signature
  • 2025-04-28 Effective date(s) 07/01/2025
  • 2025-04-28 Pub. Ch. 295

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7b282135-c886-44b0-bad3-76758bbbc006. Confidence: reported (aggregated from official Tennessee legislature records).